| [1] |
LI Yifan, QIN Chuanyu, ZENG Xi, LU Yajiao, LIAO Guangdong, KANG Leni, YANG Ying, ZHOU Min, XI Mingrong, YANG Chunxia, LI Jing.
Analysis of the acceptance and influencing factors of self-collection urine HPV testing in cervical cancer screening
[J]. Journal of Practical Oncology, 2025, 39(5): 412-417.
|
| [2] |
SU Shaofei, ZHANG Enjie, LIU Jianhui, GAO Yan.
Exploring the causal relationship between 20 metabolites and ovarian cancer risk based on Mendelian randomization
[J]. Journal of Practical Oncology, 2025, 39(3): 191-200.
|
| [3] |
WANG Mengfei, XU Boqun.
Advances in immunotherapy for locally advanced cervical cancer
[J]. Journal of Practical Oncology, 2025, 39(2): 157-161.
|
| [4] |
KOU Shuai, WANG Yuping, SUN Xiaoxia, REN Juanjuan.
Analysis of incidence and mortality of ovarian cancer in China from 1992 to 2021 based on age-period-cohort model
[J]. Journal of Practical Oncology, 2025, 39(1): 7-12.
|
| [5] |
ZHANG Hua, Nurbia Ibibulla, LU Pengfei, JIA Chunli, PEI Xuanxuan, BAO Yongxing.
Effect and mechanism of CXCL8 on the paclitaxel sensitivity of cervical cancer cells
[J]. Journal of Practical Oncology, 2025, 39(1): 13-20.
|
| [6] |
CHEN Maosen, WEN Hongmei, SHI Qingping, SHAO Ying, TANG Xian, REN Siying, CHEN Yang.
Analysis of the incidence and mortality of cervical cancer in cancer registration areas of Yunnan province in 2020 and the trend from 2012 to 2020
[J]. Journal of Practical Oncology, 2024, 38(6): 355-360.
|
| [7] |
SUN Lijun, DONG Dawei.
Classification and prognosis of ovarian cancer based on platinum resistance related genes
[J]. Journal of Practical Oncology, 2024, 38(3): 184-191.
|
| [8] |
GAO Yan, HAN Xiaoyang, CHENG Jin, HOU Lisha, YUE Wentao.
Single cell sequencing data reveal PHLDA1 as a critical molecule responsible for T cell exhaustion in ovarian cancer
[J]. Journal of Practical Oncology, 2024, 38(2): 79-87.
|
| [9] |
ZHOU Jianyun, CHU Qiaoxiang, LU Yuemei, ZHU Jing, DING Qipei.
The effects of lncRNA GAS5 on the proliferation,invasion ability and PTEN/Akt/mTOR signaling pathway of cervical cancer cells
[J]. Journal of Practical Oncology, 2024, 38(2): 96-103.
|
| [10] |
HAN Xia, DING Gaoheng, YANG Jing, LIU Yuqin, CHEN Lan, SONG Guoxian.
Epidemic characteristics of uterine body cancer in Gansu province in 2019 and its trend analysis from 2010 to 2019
[J]. Journal of Practical Oncology, 2024, 38(1): 7-12.
|
| [11] |
GAO Yan, YAO Mengcheng, LI Zhefeng, HAN Xiaoyang, YUE Wentao.
Single cell sequencing data reveal the diagnostic and predictive value of DMKN in ovarian cancer
[J]. Journal of Practical Oncology, 2023, 37(6): 478-484.
|
| [12] |
ZHUANG Yijun, SUN Yuqi, YANG Wei.
Effects of β-elemene regulating the PI3K/Akt/mTOR signaling pathway on the proliferation,migration,invasion and apoptosis of endometrial cancer Ishikawa cells
[J]. Journal of Practical Oncology, 2023, 37(5): 395-402.
|
| [13] |
FAN Tingting, DING Danni, ZHAO Zixue, YU Yang, HAN Fengjuan.
Fatty acid metabolism and ovarian cancer
[J]. Journal of Practical Oncology, 2023, 37(5): 429-433.
|
| [14] |
LI Shuzhen, CAI Zhifu, RONG Yan, PANG Yebin, LUO Dongni, GAO Kun.
Research progress of tumor volume in cervical cancer brachytherapy
[J]. Journal of Practical Oncology, 2023, 37(1): 63-67.
|
| [15] |
MIN Zhiqian, JIN Ronghui, CHEN Lihong, LEI Xiaoyan, ZHANG Xin, ZHANG Bin, YU Jiao, LIN Lili, CHEN Xiaolong.
Application of multimodal MRI in predicting parauterine invasion of stage IB1–IIA2 cervical cancer
[J]. Journal of Practical Oncology, 2022, 36(5): 424-428.
|
